GLP1R and Hyperglycemia: Thus, given the potent glucose-lowering actions of the GLP-1 receptor agonists as described (HbA1c reduction 1–1.5% and even more pronounced for the most recent long-acting GLP-1 receptor agonists), reduction in hyperglycemia may contribute to their strong anti-albuminuric effects.